Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma

Vascular Pharmacology

Volumn 48, Issue 2-3, 2008, Pages 85-91

  Batistaki, Chrysanthi ^a   Kostopanagiotou, Georgia ^a   Myrianthefs, Pavlos ^b   Dimas, Cleanthi ^a   Matsota, Paraskevi ^a   Pandazi, Aggeliki ^a   Baltopoulos, George ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

endorphin; Catecholamines; Cytokines; Shock; Trauma

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ENDORPHIN; CATECHOLAMINE; DOPAMINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APACHE; ARTICLE; BLEEDING; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE TRAUMA; PRIORITY JOURNAL;

ADULT; AGED; BETA-ENDORPHIN; CATECHOLAMINES; FEMALE; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; INTERLEUKIN-10; INTERLEUKIN-6; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, HEMORRHAGIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS AND INJURIES;

EID: 40149092926     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.12.003     Document Type: Article

References (41)

1. Armstrong L., Jordan N., and Millar A. Interleukin 10 (IL-10) regulation of tumor necrosis factor alpha (TNF-a) from human alveolar macrophages and peripheral blood monocytes. Thorax 51 (1996) 143-149
2. Bone R.C. Immunologic dissonance: a continuing evolution of our understanding of the Systemic Inflammatory Response Syndrome. Ann. Intern. Med. 125 (1996) 680-687
3. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2004) 235-272
4. Cavun S., Resch G.E., Evec A.D., Rapacon-Baker M.M., and Millington W.R. Blockade of delta opioid receptors in the ventrolateral periaqueductal grey region inhibits the fall in arterial pressure evoked by hemorrhage. J. Pharmacol. Exp. Ther. 297 (2001) 612-619
5. DeLong W.G., and Born C.T. Cytokines in patients with polytrauma. Clin. Orthop. 422 (2004) 57-65
6. Elenkov I.J., Hasko G., Kovacks K.J., et al. Modulation of lipopolysaccharide-induced tumor necrosis factor-a production by selective a- and b-adrenergic drugs in mice. J Neuroimmunol. 61 (1995) 123-131
7. Elenkov I.J., Wilder R.L., Chrousos G.P., and Visi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
8. Faden A., and Holaday J.W. Opiate antagonists: a role in the treatment of hypovolemic shock. Science (Wash DC) 205 (1979) 317-318
9. Gebhard F., Pfetch G., Steinbach G., et al. Is interleukin-6 an early marker of injury severity following major trauma in humans?. Arch. Surg. 135 (2000) 291-295
10. Gerard C., Bruyns C., and Marchant A. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177 (1993) 547-550
11. Goris R.J.A. Pathophysiology of shock in Trauma. Eur. J. Surg. 166 (2000) 100-111
12. Hoch R.C. Effects of accidental trauma on cytokine and endotoxin production. Crit. Care Med. 21 (1993) 839-845
13. Holden J.E., Jeong Y., and Forrest J.M. The endogenous opioid system and clinical pain management. AACN Clin. Issues 16 (2005) 291-301
14. Hong Meng Z., Dyer K., Billiar T.R., et al. Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am. J. Physiol. Cell Physiol. 280 (2001) C343-C351
15. Jiang J.X., Tian L., Zhu P.F., et al. Plasma cytokines and endotoxin levels in patients with severe injury and their relationship with organ damage. Injury 28 (1997) 509-513
16. Karakozis S., Hinds M., Cook J.W., et al. The effects of interleukin 10 in hemorrhagic shock. J. Surg. Res. 90 (2000) 109-112
17. Madden K.S. Catecholamines, sympathetic innervation and immunity. Brain Behav. Immun. 17 (2003) S5-S10
18. Martel M.J. Hemorrhagic shock. J. Obstet. Gynaecol. Can. 24 (2002) 504-511
19. Molina P.E. Opiate modulation of hemodynamic, hormonal and cytokine responses to hemorrhage. Shock 15 (2001) 471-478
20. Molina P.E. Stress-specific opioid modulation of haemodynamic counter-regulation. Clin. Exp. Pharmacol. Physiol. 29 (2002) 248-253
21. Molina P.E. Endogenous opioid analgesia in hemorrhagic shock. J.Trauma 54 (2003) S126-S132
22. Molina P.E., and Abumrad N.N. Differential effects of hemorrhage and LPS on tissues TNF, IL-1 and associated neuro-hormonal and opioid alteration. Life Sci. 66 (2000) 399-409
23. Molina P.E., Malek S., Lang C.H., Quian L., Naukam R., and Abumrad N.N. Early organ specific hemorrhage induced increases in tissue cytokine content. Associated neuro-hormonal and opiate alterations. J, Neuroimmunol. 4 (1997) 28-36
24. Morris M.J., Hastings J.A., and Pavia J.M. Catecholamine release in the rat hypothalamic paraventricular nucleus in response to hemorrhage, desipramine and potassium. Brain Res. 665 (1994) 5-12
25. Nast-Kolb D., Waydhas C., Gippner-Steppert C., et al. Indicators of posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries. J. Trauma 42 (1997) 446-454
26. Nicholson G., Woodfine J., Bryant A.E., et al. The hormonal and inflammatory responses to pelvic reconstructive surgery following major trauma. Injury 36 (2005) 303-309
27. O'Benar J.D., Hannon J.P., Peterson J.L., and Bossone C.A. Beta-endorphin, ACTH, and cortisol response to hemorrhage in conscious pigs. Am. J. Physiol. 252 (1987) R953-R958
28. Oliver J.C., Bland L.A., Oettinger C.W., et al. Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res. 12 (1993) 115-120
29. Rabinovici R., John R., Esser K.M., et al. Serum tumor necrosis factor-alpha profile in trauma patients. J. Trauma 35 (1993) 698-702
30. Rongione A.J., Kusske A.M., and Ashley S.W. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J. Surg. Res. 70 (1997) 107-112
31. Rose S., and Marzi I. Mediators in polytrauma-pathophysiological significance and clinical relevance. Langenbecks Arch. Surg. 383 (1998) 199-208
32. Sakamoto K., Arakawa H., Mita S., et al. Elevation of circulating interleukin-6 after surgery. Factors influencing the serum level. Cytokine 6 (1994) 181-186
33. Seyle H. Stress in Health and Disease (1976), Butterworth, London
34. Solomkin J.S. Focus on 'Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock'. Am. J. Physiol. Cell Physiol. 280 (2001) C237-C238
35. Spielmann T., Kerner T., and Ahlers D. Early detection of increased tumour necrosis factor alpha (TNFa) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course. Acta Anaesthesiol. Scand. 45 (2001) 364-370
36. Sprengler R.N., Allen R.M., Remick D.G., et al. Stimulation of a-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145 (1990) 1430-1434
37. Svoboda P., Kantorova I., and Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J. Trauma 36 (1994) 336-340
38. Thomson A. Τhe Cytokine Handbook Academic Press Limited (1998)
39. Torres K., Antonelli R., Souza A., et al. Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J. Neuroimmunol. 166 (2005) 144-157
40. Van der Poll T., Jansen J., Endert E., et al. Noradrenaline inhibits lipopolysacharide induced tumor necrosis factor and interleukin 6 production in human whole blood. Immune (1994) 2046-2050
41. Wollemann M., and Benyhe S. Non-opioid actions of opioid peptides. Life Sci. 75 (2004) 257-270